Yasmin and insurance coverage: what to expect — for Australia
Whether Yasmin (Drospirenone / Ethinyl Estradiol) is covered by insurance or a public health system depends on the medication, the formulary tier, and the patient's contribution group or plan. For chronic use of Yasmin at 3mg / 0.03mg, coverage is usually the dominant economic factor — far more than the official retail price.
Australia context
Coverage of Yasmin in Australia depends on the public system, the private insurer or the pharmacy benefit. Australia's medications are scheduled S1 through S10; Schedule 4 (prescription only) and Schedule 8 (controlled drugs) require written or e-prescriptions. The Pharmaceutical Benefits Scheme (PBS) subsidises most prescription costs to a fixed patient co-payment. Authorised generics of Drospirenone, Ethinyl Estradiol are usually preferred-tier and lower-cost; branded Yasmin sits at a higher tier or may require prior authorisation. Out-of-pocket cost in AUD can vary substantially between plans.
- Regulator
- TGA (Therapeutic Goods Administration)
- Currency
- AUD
How coverage works
Most insurers and public systems use a formulary that lists which medications are covered, at which tier (preferred generic, preferred brand, non-preferred, specialty), and with what out-of-pocket contribution. Yasmin sits somewhere on this list depending on whether the active ingredient Drospirenone, Ethinyl Estradiol has authorised generics, the negotiated price and the system's cost-effectiveness assessment for Women's Sexual Health.
Practical considerations
According to general health-insurance practice, prior authorisation is sometimes required before Yasmin is covered — particularly for the brand version when an authorised generic exists. Step therapy may require trying a generic first. The pharmacist can usually confirm whether a specific Yasmin prescription is covered and what the patient pays, often before the prescription is dispensed at 3mg / 0.03mg.
Frequently asked questions
Is Yasmin covered by insurance? ▾
Coverage of Yasmin depends on the specific insurer or public system, the formulary tier and any prior-authorisation rules. Authorised generics of Drospirenone, Ethinyl Estradiol are typically covered at the lowest cost tier, while branded Yasmin sits on a higher tier with more out-of-pocket spend.
How much will Yasmin cost out of pocket? ▾
Out-of-pocket cost depends on the plan tier, deductible status and copay. Authorised generics of Drospirenone, Ethinyl Estradiol usually cost a fraction of the brand. The pharmacy can run the prescription against the plan and quote the actual price for Yasmin at 3mg / 0.03mg before dispensing.
Yasmin and insurance coverage: what to expect in other countries
- the United StatesFDA (Food and Drug Administration)
- the United KingdomMHRA (Medicines and Healthcare products Regulatory Agency)
- SpainAEMPS (Agencia Española de Medicamentos y Productos Sanitarios)
- MexicoCOFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios)
- ArgentinaANMAT (Administración Nacional de Medicamentos, Alimentos y Tecnología Médica)
- GermanyBfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
- FranceANSM (Agence nationale de sécurité du médicament et des produits de santé)
- ItalyAIFA (Agenzia Italiana del Farmaco)
- BrazilANVISA (Agência Nacional de Vigilância Sanitária)
The information on this website is provided for reference and educational purposes only. It does not replace consultation with a qualified healthcare professional.